221 related articles for article (PubMed ID: 15356029)
1. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.
Ibáñez L; Valls C; Marcos MV; Ong K; Dunger DB; De Zegher F
J Clin Endocrinol Metab; 2004 Sep; 89(9):4331-7. PubMed ID: 15356029
[TBL] [Abstract][Full Text] [Related]
2. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome.
Ibáñez L; Ferrer A; Ong K; Amin R; Dunger D; de Zegher F
J Pediatr; 2004 Jan; 144(1):23-9. PubMed ID: 14722514
[TBL] [Abstract][Full Text] [Related]
3. Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche.
Ibáñez L; López-Bermejo A; Díaz M; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 2008 May; 93(5):1841-5. PubMed ID: 18319306
[TBL] [Abstract][Full Text] [Related]
4. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche.
Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 2000 Oct; 85(10):3526-30. PubMed ID: 11061495
[TBL] [Abstract][Full Text] [Related]
5. Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence.
Ibáñez L; López-Bermejo A; Díaz M; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1262-7. PubMed ID: 21632811
[TBL] [Abstract][Full Text] [Related]
6. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Ibáñez L; de Zegher F
J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
[TBL] [Abstract][Full Text] [Related]
7. Metformin treatment to prevent early puberty in girls with precocious pubarche.
Ibáñez L; Ong K; Valls C; Marcos MV; Dunger DB; de Zegher F
J Clin Endocrinol Metab; 2006 Aug; 91(8):2888-91. PubMed ID: 16684823
[TBL] [Abstract][Full Text] [Related]
8. Early metformin therapy to delay menarche and augment height in girls with precocious pubarche.
Ibáñez L; Lopez-Bermejo A; Diaz M; Marcos MV; de Zegher F
Fertil Steril; 2011 Feb; 95(2):727-30. PubMed ID: 20883985
[TBL] [Abstract][Full Text] [Related]
9. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.
Ibáñez L; Valls C; Cabré S; De Zegher F
J Clin Endocrinol Metab; 2004 Sep; 89(9):4716-20. PubMed ID: 15356085
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess.
Lázaro I; Díaz M; Cabré A; Masana L; Ibáñez L
Gynecol Endocrinol; 2011 Nov; 27(11):935-9. PubMed ID: 21605000
[TBL] [Abstract][Full Text] [Related]
11. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
Ibáñez L; Ong K; Ferrer A; Amin R; Dunger D; de Zegher F
J Clin Endocrinol Metab; 2003 Jun; 88(6):2600-6. PubMed ID: 12788862
[TBL] [Abstract][Full Text] [Related]
12. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.
Ibáñez L; de Zegher F
J Clin Endocrinol Metab; 2005 Jan; 90(1):39-43. PubMed ID: 15483105
[TBL] [Abstract][Full Text] [Related]
13. Anovulation in eumenorrheic, nonobese adolescent girls born small for gestational age: insulin sensitization induces ovulation, increases lean body mass, and reduces abdominal fat excess, dyslipidemia, and subclinical hyperandrogenism.
Ibáñez L; Potau N; Ferrer A; Rodriguez-Hierro F; Marcos MV; De Zegher F
J Clin Endocrinol Metab; 2002 Dec; 87(12):5702-5. PubMed ID: 12466374
[TBL] [Abstract][Full Text] [Related]
14. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
15. The effect of metformin on low birth weight girls with precocious puberty: A protocol for systematic review and meta-analysis.
Lin Z; Sui X; Li L; Wang Y; Zhao J
Medicine (Baltimore); 2022 Jul; 101(26):e29765. PubMed ID: 35776991
[TBL] [Abstract][Full Text] [Related]
16. Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.
Ibáñez L; Valls C; Ferrer A; Ong K; Dunger DB; De Zegher F
J Clin Endocrinol Metab; 2002 Jun; 87(6):2870-4. PubMed ID: 12050266
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 in girls with precocious pubarche: a premenarcheal marker for polycystic ovary syndrome?
Ibáñez L; Aulesa C; Potau N; Ong K; Dunger DB; de Zegher F
Pediatr Res; 2002 Feb; 51(2):244-8. PubMed ID: 11809921
[TBL] [Abstract][Full Text] [Related]
18. Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche.
Ibáñez L; Ong K; de Zegher F; Marcos MV; del Rio L; Dunger DB
Clin Endocrinol (Oxf); 2003 Mar; 58(3):372-9. PubMed ID: 12608944
[TBL] [Abstract][Full Text] [Related]
19. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
Loverro G; Lorusso F; De Pergola G; Nicolardi V; Mei L; Selvaggi L
Gynecol Endocrinol; 2002 Jun; 16(3):217-24. PubMed ID: 12192894
[TBL] [Abstract][Full Text] [Related]
20. Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect.
Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F
Clin Endocrinol (Oxf); 2001 Nov; 55(5):667-72. PubMed ID: 11894979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
